AAAAAA
Results: 51-75/123
Authors:
SCHOTT ME
WELLS DT
SCHLOM J
ABRAMS SI
Citation: Me. Schott et al., COMPARISON OF LINEAR AND BRANCHED PEPTIDE FORMS (MAPS) IN THE INDUCTION OF T-HELPER RESPONSES TO POINT-MUTATED RAS IMMUNOGENS, Cellular immunology, 174(2), 1996, pp. 199-209
Authors:
GUADAGNI F
ROSELLI M
COSIMELLI M
SPILA A
CAVALIERE F
TEDESCO M
ARCURI R
ABBOLITO MR
CASALE V
PERICOLI MN
VECCHIONE A
CASCIANI CU
GREINER JW
SCHLOM J
Citation: F. Guadagni et al., CORRELATION BETWEEN TUMOR-ASSOCIATED GLYCOPROTEIN-72 MUCIN LEVELS IN TUMOR AND SERUM OF COLORECTAL PATIENTS AS MEASURED BY THE QUANTITATIVECA-72-4 IMMUNOASSAY, Cancer research, 56(22), 1996, pp. 5293-5298
Authors:
LIN L
DAUGHERTY B
SCHLOM J
PESTKA S
Citation: L. Lin et al., CONSTRUCTION OF PHOSPHORYLATABLE MONOCLONAL-ANTIBODY TO A TUMOR-ASSOCIATED ANTIGEN, Cancer research, 56(18), 1996, pp. 4250-4254
Authors:
MCLAUGHLIN JP
SCHLOM J
KANTOR JA
GREINER JW
Citation: Jp. Mclaughlin et al., IMPROVED IMMUNOTHERAPY OF A RECOMBINANT CARCINOEMBRYONIC ANTIGEN VACCINIA VACCINE WHEN GIVEN IN COMBINATION WITH INTERLEUKIN-2, Cancer research, 56(10), 1996, pp. 2361-2367
Authors:
TSANG KY
ZAREMBA S
NIERODA CA
ZHU MZ
HAMILTON JM
SCHLOM J
Citation: Ky. Tsang et al., GENERATION OF HUMAN CYTOTOXIC T-CELLS SPECIFIC FOR HUMAN CARCINOEMBRYONIC ANTIGEN EPITOPES FROM PATIENTS IMMUNIZED WITH RECOMBINANT VACCINIA-CEA VACCINE, Journal of the National Cancer Institute, 87(13), 1995, pp. 982-990
Authors:
MULLIGAN T
CARRASQUILLO JA
CHUNG Y
MILENIC DE
SCHLOM J
FEUERSTEIN I
PAIK C
PERENTESIS P
REYNOLDS J
CURT G
GOECKELER W
FORDYCE W
CHENG R
RISEBERG D
COWAN K
OSHAUGHNESSY J
Citation: T. Mulligan et al., PHASE-I STUDY OF INTRAVENOUS LU-177-LABELED CC49 MURINE MONOCLONAL-ANTIBODY IN PATIENTS WITH ADVANCED ADENOCARCINOMA, Clinical cancer research, 1(12), 1995, pp. 1447-1454
Authors:
DIVGI CR
SCOTT AM
GULEC S
BROUSSARD EK
LEVY N
YOUNG C
CAPITELLI P
DAGHIGHIAN F
WILLIAMS JM
FINN RD
KEMENY N
HILTON S
KELSEN D
MILENIC DE
LORA ME
SCHLOM J
LARSON SM
Citation: Cr. Divgi et al., PILOT RADIOIMMUNOTHERAPY TRIAL WITH I-131-LABELED MURINE MONOCLONAL-ANTIBODY CC49 AND DEOXYSPERGUALIN IN METASTATIC COLON-CARCINOMA, Clinical cancer research, 1(12), 1995, pp. 1503-1510
Authors:
DANSKYULLMANN C
SALGALLER M
ADAMS S
SCHLOM J
GREINER JW
Citation: C. Danskyullmann et al., SYNERGISTIC EFFECTS OF IL-6 AND IFN-GAMMA ON CARCINOEMBRYONIC ANTIGEN(CEA) AND HLA EXPRESSION BY HUMAN COLORECTAL-CARCINOMA CELLS - ROLE FOR ENDOGENOUS IFN-BETA, Cytokine, 7(2), 1995, pp. 118-129
Authors:
NICOLET CM
BURKHOLDER JK
GAN J
CULP J
KASHMIRI SVS
SCHLOM J
YANG NS
SONDEL PM
Citation: Cm. Nicolet et al., EXPRESSION OF A TUMOR-REACTIVE ANTIBODY-INTERLEUKIN-2 FUSION PROTEIN AFTER IN-VIVO PARTICLE-MEDIATED GENE DELIVERY, Cancer gene therapy, 2(3), 1995, pp. 161-170
Authors:
MYERS RB
SCHLOM J
SRIVASTAVA S
GRIZZLE WE
Citation: Rb. Myers et al., EXPRESSION OF TUMOR-ASSOCIATED GLYCOPROTEIN-72 IN PROSTATIC INTRAEPITHELIAL NEOPLASIA AND PROSTATIC ADENOCARCINOMA, Modern pathology, 8(3), 1995, pp. 260-265
Authors:
BEI R
PARANAVITANA C
MILENIC D
KASHMIRI SVS
SCHLOM J
Citation: R. Bei et al., GENERATION, PURIFICATION, AND CHARACTERIZATION OF A RECOMBINANT SOURCE OF HUMAN PROSTATE-SPECIFIC ANTIGEN, Journal of clinical laboratory analysis, 9(4), 1995, pp. 261-268
Authors:
GUADAGNI F
ROSELLI M
COSIMELLI M
FERRONI P
SPILA A
CAVALIERE F
CASALDI V
WAPPNER G
ABBOLITO MR
GREINER JW
SCHLOM J
Citation: F. Guadagni et al., CA-72-4 SERUM MARKER - A NEW TOOL IN THE MANAGEMENT OF CARCINOMA PATIENTS, Cancer investigation, 13(2), 1995, pp. 227-238
Authors:
KASHMIRI SVS
SHU L
PADLAN EA
MILENIC DE
SCHLOM J
HAND PH
Citation: Svs. Kashmiri et al., GENERATION, CHARACTERIZATION, AND IN-VIVO STUDIES OF HUMANIZED ANTICARCINOMA ANTIBODY CC49, Hybridoma, 14(5), 1995, pp. 461-473
Authors:
SCHLOM J
Citation: J. Schlom, HUMANIZED (HU) CC49 ANTIGEN IS TUMOR-ASSOCIATED GLYCOPROTEIN (TAG)-72, Hybridoma, 14(5), 1995, pp. 516-516
Authors:
ROSELLI M
HITCHCOCK CL
MOLINOLO A
MILENIC DE
COLCHER D
MARTIN EW
HINKLE GH
SCHLOM J
Citation: M. Roselli et al., AUTORADIOGRAPHIC EVALUATION OF RADIOLABELED MONOCLONAL-ANTIBODY B72.3DISTRIBUTION IN TUMOR AND LYMPH-NODES OF ADENOCARCINOMA PATIENTS, Anticancer research, 15(3), 1995, pp. 975-984
Authors:
GOLDENBERG DM
LARSON SM
REISFELD RA
SCHLOM J
Citation: Dm. Goldenberg et al., TARGETING CANCER WITH RADIOLABELED ANTIBODIES, Immunology today, 16(6), 1995, pp. 261-264
Authors:
QI CF
NIERODA C
DEFILIPPI R
GREINER JW
CORREALE P
SCHLOM J
TSANG KY
Citation: Cf. Qi et al., MACROPHAGE-COLONY-STIMULATING FACTOR ENHANCEMENT OF ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY AGAINST HUMAN COLON-CARCINOMA CELLS, Immunology letters, 47(1-2), 1995, pp. 15-24
Authors:
DIVGI CR
SCOTT AM
DANTIS L
CAPITELLI P
SILER K
HILTON S
FINN RD
KEMENY N
KELSEN D
KOSTAKOGLU L
SCHLOM J
LARSON SM
Citation: Cr. Divgi et al., PHASE-I RADIOIMMUNOTHERAPY TRIAL WITH IODINE-131-CC49 IN METASTATIC COLON-CARCINOMA, The Journal of nuclear medicine, 36(4), 1995, pp. 586-592
Authors:
BEI R
SCHLOM J
KASHMIRI SVS
Citation: R. Bei et al., BACULOVIRUS EXPRESSION OF A FUNCTIONAL SINGLE-CHAIN IMMUNOGLOBULIN AND ITS IL-2 FUSION PROTEIN, Journal of immunological methods, 186(2), 1995, pp. 245-255
Authors:
HODGE JW
SCHLOM J
DONOHUE SJ
TOMASZEWSKI JE
WHEELER CW
LEVINE BS
GRITZ L
PANICALI D
KANTOR JA
Citation: Jw. Hodge et al., A RECOMBINANT VACCINIA VIRUS EXPRESSING HUMAN PROSTATE-SPECIFIC ANTIGEN (PSA) - SAFETY AND IMMUNOGENICITY IN A NONHUMAN PRIMATE, International journal of cancer, 63(2), 1995, pp. 231-237
Authors:
ABRAMS SI
DOBRZANSKI MJ
WELLS DT
STANZIALE SE
ZAREMBA S
MASUELLE L
KANTOR JA
SCHLOM J
Citation: Si. Abrams et al., PEPTIDE-SPECIFIC ACTIVATION OF CYTOLYTIC CD4(-LYMPHOCYTES AGAINST TUMOR-CELLS BEARING MUTATED EPITOPES OF K-RAS P21() T), European Journal of Immunology, 25(9), 1995, pp. 2588-2597
Authors:
MURRAY JL
MACEY DJ
GRANT EJ
ROSENBLUM MG
KASI LP
ZHANG HZ
GATZ RL
RIEGER PT
LEBHERZ D
BHADKAMKAR V
GREINER JW
SCHLOM J
PODOLOFF DA
Citation: Jl. Murray et al., ENHANCED TAG-72 EXPRESSION AND TURNER UPTAKE OF RADIOLABELED MONOCLONAL-ANTIBODY CC49 IN METASTATIC BREAST-CANCER PATIENTS FOLLOWING ALPHA-INTERFERON TREATMENT, Cancer research, 55(23), 1995, pp. 5925-5928
Authors:
SLAVINCHIORINI DC
KASHMIRI SVS
SCHLOM J
CALVO B
SHU LM
SCHOTT ME
MILENIC DE
SNOY P
CARRASQUILLO J
ANDERSON K
HAND PH
Citation: Dc. Slavinchiorini et al., BIOLOGICAL PROPERTIES OF CHIMERIC DOMAIN-DELETED ANTICARCINOMA IMMUNOGLOBULINS, Cancer research, 55(23), 1995, pp. 5957-5967
Authors:
SALEH MN
KHAZAELI MB
WHEELER RH
BUCY RP
LIU TP
EVERSON MP
MUNN DH
SCHLOM J
LOBUGLIO AF
Citation: Mn. Saleh et al., PHASE-II TRIAL OF MURINE MONOCLONAL-ANTIBODY D612 COMBINED WITH RECOMBINANT HUMAN MONOCYTE COLONY-STIMULATING FACTOR (RHM-CSF) IN PATIENTS WITH METASTATIC GASTROINTESTINAL CANCER, Cancer research, 55(19), 1995, pp. 4339-4346
Authors:
HODGE JW
MCLAUGHLIN JP
ABRAMS SI
SHUPERT WL
SCHLOM J
KANTOR JA
Citation: Jw. Hodge et al., ADMIXTURE OF A RECOMBINANT VACCINIA VIRUS CONTAINING THE GENE FOR THECOSTIMULATORY MOLECULE B7 AND A RECOMBINANT VACCINIA VIRUS CONTAININGA TUMOR-ASSOCIATED ANTIGEN GENE RESULTS IN ENHANCED SPECIFIC T-CELL RESPONSES AND ANTITUMOR IMMUNITY, Cancer research, 55(16), 1995, pp. 3598-3603